1. Home
  2. VVOS vs CTXR Comparison

VVOS vs CTXR Comparison

Compare VVOS & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$1.06

Market Cap

19.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
CTXR
Founded
2016
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
19.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
VVOS
CTXR
Price
$2.07
$1.06
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$6.25
$6.00
AVG Volume (30 Days)
123.1K
560.0K
Earning Date
11-19-2025
12-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,317,000.00
N/A
Revenue This Year
$17.96
N/A
Revenue Next Year
$55.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.76
N/A
52 Week Low
$1.98
$0.65
52 Week High
$7.95
$5.95

Technical Indicators

Market Signals
Indicator
VVOS
CTXR
Relative Strength Index (RSI) 38.11 41.91
Support Level $1.98 $1.12
Resistance Level $2.28 $1.20
Average True Range (ATR) 0.13 0.12
MACD 0.02 -0.01
Stochastic Oscillator 25.71 0.00

Price Performance

Historical Comparison
VVOS
CTXR

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: